Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Does caffeine prevent hypoxaemic episodes in premature infants?

A randomized controlled trial

  • 92 Accesses

  • 30 Citations

Abstract

Fifty spontaneously breathing, preterm infants 48h old, of 32 weeks' gestation or less, were assigned randomly to receive caffeine citrate (loading dose 20 mg/kg, maintenance dose 10 mg/kg per day) or a placebo (NaCl 0.9%). The study hypothesis was that caffeine reduces the proportion of infants with recurrent hypoxaemic episodes (decrease in transcutaneous PO2 of 20% within 20ss) from 50% to 25%. Transcutaneous oxygen tension (tcPO2) and heart rate were recorded continuously for 50h and analysed by computer. The two groups were similar in gestational age, birth weight, delivery mode, sex distribution, and Apgar scores. The mean serum concentration (±SD) of caffeine 2h after the second maintenance dose was 96.0 (±34.5) μmol/l in the group receiving caffeine and 9.3 (±12.8) μmol/l in the group receiving a placebo. The mean proportion of infants with more than six hypoxaemic episodes per 12h in the caffeine groups was higher (57%) than in the control group (51%). The mean proportion of infants with more than six episodes of bradycardia per 12h was not statistically different in the caffeine group (79%) from the control group (86%). Our results suggest that prophylactic caffeine has little if any effect on the risk of developing hypoxaemic episodes and bradycardia in small preterm infants and the supposed 50% reduction which was considered clinically important at the start of the trial can be rejected with confidence.

This is a preview of subscription content, log in to check access.

Abbreviations

tePO2 :

transcutaneous oxygen tension

References

  1. 1.

    Aranda JV, Gorman W, Bergsteinsson H, Gunn T (1977) Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 90:467–472

  2. 2.

    Bucher HU, Fallenstein F, Mieth D, Duc G (1985) Efficacy of low and high dose caffeine on idiopathic bradycardia and hypoxemia in premature infants. Helv Paediatr Acta 40:153–162

  3. 3.

    Bulpitt CJ (1983) Randomised controlled clinical trials. Martinus Nijhoff, The Hague

  4. 4.

    Clark CJ, Downie CC (1966) A method for the rapid determination of the number of patients to include in a controlled clinical trial. Lancet II:1357–1358

  5. 5.

    Detsky AS, Sackett DL (1985) When was a “negative” clinical trial big enough? Arch Intern Med 145:709–712

  6. 6.

    Gore SM (1981) Statistics in question. Assessing methods-confidence intervals. Br Med J 283:660–662

  7. 7.

    Hrbek A, Karlberg P, Kjellmar I, Olsson T, Riha M (1978) Clinical application of evoked EEG-responses in newborn infants. II. Idiopathic respiratory distress syndrome. Dev Med Child Neurol 20:619–626

  8. 8.

    Hurt CE, Brouillette RT, Liu K, Klemka L (1985) Day-to-day pneumogram variability. Pediatr Res 19:174–177

  9. 9.

    Koppe JG, de Bruijne JI, de Boer P (1979) Apneic spells and transcutaneous Po2: treatment with caffeine, 19 year follow-up. Birth Defects 15:437–445

  10. 10.

    McDonald A (1963) Cerebral palsy in children of very low birth weight. Arch Dis Child 38:579–588

  11. 11.

    Murat I, Moriette G, Blin D, Couchard M, Flouvat B, De Gamarra E, Relier JP, Dreyfus-Brisac C (1981) The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J Pediatr 99:984–989

  12. 12.

    Peabody JL, Gregory GA, Willis MM, Philip AGS, Lucey JF (1979) Failure of conventional monitoring to detect apnea resulting in hypoxemia. Birth Defects 15:275–284

  13. 13.

    Saint-Martin J, Duhamel S, Choulot JJ (1980) Utilisation de la caféine dans les apnées du prématuré. Pédiatrie 35:21–27

  14. 14.

    Silverman WA (1985) Human experimentation. A guided step to the unknown. University Press, Oxford, pp 112–126

  15. 15.

    Southall DP, Levitt GA, Richards JM, Jones RAK, Kong C, Farndon PA, Alexander JR, Wilson AJ (1983) Undetected episodes of prolonged apnea and severe bradycardia in preterm infants. Pediatrics 72:541–551

  16. 16.

    Tönz O, Schubiger G (1985) Feeding of very-low-birth-weight infants with breast milk enriched by energy, nitrogen and minerals: FM85. Helv Paediatr Acta 40:235–247

  17. 17.

    Trounce JQ, Levene MI (1985) Diagnosis and outcome of subcortical cystic leucomalacia. Arch Dis Child 60:1041–1044

Download references

Author information

Correspondence to H. U. Bucher.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bucher, H.U., Duc, G. Does caffeine prevent hypoxaemic episodes in premature infants?. Eur J Pediatr 147, 288–291 (1988). https://doi.org/10.1007/BF00442697

Download citation

Key words

  • Premature infant
  • Caffeine
  • Hypoxaemia
  • Bradycardia